Gynecology
| FRIDAY, NOVEMBER 11TH, 2016 HALL C |
|
| 08:30-10:00 | URODYNAMIC INVESTIGATION IN SUI |
| Chairperson | C.H. van der Vaart, The Netherlands |
| 08:30-09:15 | Debate: Does multi-channel urodynamics have value in evaluation of SUI? In favor: Gommert van Koeveringe, The Netherlands Against: Jan Paul Roovers, The Netherlands Discussion |
| 09:15-09:40 | Treatment of drug-refractory overactive bladder (Botox, sacral neurmodulation, tibial nerve stimulation) Laetitia de Kort, The Netherlands |
| 09:40-10:00 | Treatment of pelvic floor dysfunction using erbium laser Aleksandra Novakov Mikic, Serbia |
| 10:20-11:50 | HPV SCREENING AND SCREENING STRATEGIES |
| Capsule | Most European recommendations support the adoption of validated HPV tests as the stand-alone primary screening tool. Coordinated strategies of screening and vaccination are the subject of intense research and evaluation |
| Chairpersons | F. Xavier Bosch, Spain Chris J.M. Meijer, The Netherlands |
| 10:20-10:40 | Introduction: The need for coordinated programs of vaccination and screening F. Xavier Bosch, Spain |
| 10:40-11:10 | The indications and the guidelines of HPV testing in Europe Marc Arbyn, Belgium |
| 11:10-11:40 | The complexities of adopting HPV screening by population based programs Peter J.F. Snijders, The Netherlands |
| 11:40-11:50 | Discussion: The impact of HPV screening in the private practice |
| 12:10-13:40 | POTENTIAL TREATMENT OF BREAST AND PROSTATIC CANCER |
| Capsule | Estrogens are effective for the treatment of breast- and prostate cancer, but failed in the past due to side effects. The fetal SERM estetrol (E4) may become a new treatment option for these hormone sensitive cancers |
| Chairpersons | Bart C.J.M. Fauser, The Netherlands Herjan Coelingh Bennink, The Netherlands |
| 12:10-12:30 | High dose estrogen treatment of breast cancer Herjan Coelingh Bennink, The Netherlands |
| 12:30-12:55 | Treatment of breast cancer with high dose estetrol Carole Verhoeven, The Netherlands |
| 12:55-13:15 | E4 and prostate cancer Yvette Zimmerman, The Netherlands |
| 13:15-13:40 | Breast Cancer: Molecular and hormonal mechanism for metastasis Andrea R. Genazzani, Matias Sanchez, Marina Ines Flamini, Tommaso Simoncini Italy, Argentina |
| 14:30-16:00 | SEX AND THE PELVIC FLOOR |
| Capsule | Sexual pain is a highly prevalent complaint and involves sexual, psychological, medical and musceloskeletal aspects. The gynaecologist is almost always involved in taking care of women with sexual pain. What should gynaecologists know about the non-gynaecological factors involved in this multifactorial problem in order to be effective caregivers? |
| Chairpersons | Rik H.W. van Lunsen, The Netherlands Andrea Genazzani, Italy |
| 14:30-15:00 | The pelvic floor: A neglected contributor of vulvar pain in the lifespan: Medical considerations Alessandra Graziottin, Italy |
| 15:00-15:30 | The Pelvic Floor: A sexual organ and mirror of the soul Rik H.W. van Lunsen, The Netherlands |
| 15:30-16:00 | Integrated multidisciplinary treatment of sexual pain disorders Talli Y. Rosenbaum, Israel |
| 16:30-18:00 | HPV VACCINES: LIGHTS AND SHADOWS |
| Capsule | In spite of massive data confirming the effectiveness and safety of HPV vaccines, some vaccination programs in the world have been challenged by non-scientifically supported claims of side effects |
| Chairpersons | F. Xavier Bosch, Spain Elmar A. Joura, Austria |
| 16:30-16:50 | Introduction: The adoption of HPV vaccines in the world and the axes of assessment of vaccine safety F. Xavier Bosch, Spain |
| 16:50-17:20 | Vaccine confidence and vaccine hesitancy Heidi J. Larson, UK |
| 17:20-17:50 | The promises of the HPV vaccines Elmar A. Joura, Austria |
| 17:50-18:00 | Discussion: The role of the gynecologists in HPV vaccination |
| SATURDAY, NOVEMBER 12TH, 2016 HALL C |
|
| 08:30-10:00 | ADOLESCENT GYNECOLOGY (I) Organized by the Federation Internationale de Gynecologie Infantile et Juvenile (FIGIJ) |
| Chairpersons | Gabriele Tridenti, Italy George K. Creatsas, Greece |
| 08:30-09:00 | Usefulness of nonavalent HPV vaccine in sexually abused adolescents Mireille Merckx, Belgium |
| 09:00-09:30 | Oocyte cryopreservation in high risk girls and adolescents Evelien Roos, The Netherlands |
| 09:30-10:00 | Pregnancy in adolescence Gabriele Tridenti, Italy |
| 10:20-11:50 | ADOLESCENT GYNECOLOGY (II) |
| Chairpersons | Christian Egarter, Austria Mireille Merckx, Belgium |
| 10:20-10:40 | Vulvovaginal Congenital Anomalies George K. Creatsas, Greece |
| 10:40-11:05 | Dysfunctional uterine bleeding Lydia Marié-Scemama, France |
| 11:05-11:30 | Extended regimen OF OC’s Alessandra Graziottin, Italy |
| 11:30-11:50 | Deficiencies in the adolescent: Key supplementations Santiago Palacios, Spain |
| 12:10-13:40 | MANAGING FIBROIDS |
| Capsule | Choosing the right operative procedure where appropriate remains a challenge |
| Chairpersons | Pierluigi Benedetti Panici, Italy Alessandra Graziottin, Italy |
| 12:10-12:30 | Uterine myomas: Health and sexual challenges with a new perspective Alessandra Graziottin, Italy |
| 12:30-12:55 | Myomas: Prime time for HIFU in gynecological clinical practice? Franco Orsi, Italy |
| 12:55-13:15 | Myometcomy by minilaparotomy: The best option? Pierluigi Benedetti Panici, Italy |
| 13:15-13:40 | Laparoscopic myomectomy Jacques Donnez, Belgium |
| 14:30-16:00 | NON HORMONAL MANAGEMENT OF MENOPAUSE |
| Capsule | The slow bouncing of hormonal prescriptions requires a different solution |
| Chairpersons | Santiago Palacios, Spain Yuliya Savochkina, Russia |
| 14:30-14:50 | HRT and Osteoporosis Prevention: Are we under-using the best treatment option? Robert Langer, USA |
| 14:50-15:15 | Erbium laser treatment of pelvic organ prolapses – 3 years’ follow-up Sabina Sencar, Slovenia |
| 15:15-15:35 | The new paradigm for menopausal therapy Christian Egarter, Austria |
| 15:35-16:00 | Non-hormonal treatment of menopause Sven O. Skouby, Denmark |
| 16:30-18:00 | POTENTIAL THERAPY IN MENOPAUSE |
| Organized by the European Menopause and Andropause Society (EMAS) | |
| Chairpersons | Santiago Palacios, Spain Mark Brincat, Malta |
| 16:30-16:55 | Can ovarian response to stimulation predict early menopause Frank J.M. Broekmans, The Netherlands |
| 16:55-17:15 | Delaying menopause by ovarian tissue banking Jacques Donnez, Belgium |
| 17:15-18:00 | Debate: HRT with proper timing and chosen regimen, HT is cardiovascular protective Yes: Robert Langer, USA No: Sven O. Skouby, Denmark Discussion |